|Years old:||I'm 23 years old|
It has been reported that 2C-B induces mild psychedelic effects, although its acute pharmacological effects and pharmacokinetics have not yet been fully studied in humans. An observational study was conducted to assess the acute subjective and physiological effects, as well as pharmacokinetics of 2C-B.
Sixteen healthy, experienced drug users self-administered an oral dose of 2C-B 10, 15, or 20 mg. Vital s blood pressure and heart rate were measured at baseline 1, 2, 3, 4, and 6 hours h. Oral fluid saliva was collected to assess 2C-B and cortisol concentrations during 24 h. Acute administration of 2C-B increased blood pressure and heart rate.
Mild hallucinating effects were described in five subjects. Maximum concentrations of 2C-B and cortisol were reached at 1 and 3 h after self-administration, respectively. Psychedelics have been traditionally classified by either their chemical structure or primary mechanism of action into two classes: serotonergic hallucinogens indolamines, e. Recently, however, new psychoactive substances NPSs developed from both substitutions and well-known structures have emerged.
All of them are phenylethylamine derivatives structurally 2cb urine test to mescaline with methoxy substitutions at the 2 and 5 positions derived from the two carbon molecules between the benzene ring and the amino group. From a pharmacological point of view, preclinical studies have demonstrated that 2C-drugs inhibit the norepinephrine NE and serotonin transporters NET and SERT, respectively with very low potency in comparison to amphetamines Glennon et al.
Other studies however have reported that may act as a 5HT 2A full antagonist Villalobos et al. The metabolism of 2C-B has been studied in experimental animals and in vivo models Kanamori et al.
Urine analysis from a 2C-B abuser have identified and quantified unchanged 2C-B and nine different metabolites suggesting that 2C-B is metabolized to an alcoholic metabolite [4-bromo-2,5-dimethoxyphenylethylalcohol 2C-B-ALC ], and a carboxylated metabolite [4-bromo-2,5-dimethoxyphenylacetic acid 2C-B-CBA Kanamori et al. Currently, there are not data available describing active metabolites that could contribute to overall effects, therefore, 2C-B seems the active one while the rest are inactive or nearly so.
The drug abuse scenario
Data concerning prevalence and patterns of use of novel psychedelics are limited. Of these, In a cross-sectional survey carried out at music festivals among 2cb urine test chemical users, the most frequent substance employed was 2C-B Estimated life-time and past year use of 2C-B was 5. Globally, 6. Tablets typically contain 5—10 mg of the substance. With 2cb urine test exception of emerging 2C-B research performed in the s—s by Shulgin, who reported a maximum oral dose of mg without apparent harm Shulgin and Carter, ; Shulgin and Shulgin,limited clinical research has been conducted in humans.
Current evidence about 2C-B acute effects in humans comes from intoxications collected at Poison Information Centers Burns et al. While a of fatalities have been linked to other substances in the 2C-drug group none have been attributed to 2C-B alone. We have recently published a manuscript about the acute pharmacological effects of 2C-B focused on emotions.
The purpose of the present study is to assess the acute pharmacological effects and oral fluid pharmacokinetics of 2C-B in humans. Sixteen healthy volunteers were included eight males and eight females. Subjects were recreational drug users who reported having used 2C-B at least once in their lives. Exclusion criteria were history of any serious medical or mental disorder including drug dependence except for nicotineuse of chronic medication, and serious adverse reactions with 2C-B. The protocol was approved by the Local Human Research Ethical Committee CEIC Parc de Salut Mar, Barcelona, Spain and all the participants were informed about the purpose and procedures of the study, and ed an informed consent prior to any study-related procedure.
The study was conducted in accordance with 2cb urine test Declaration of Helsinki. Participants received financial compensation for their participation. A non-controlled prospective observational study was conducted. Each subject participated in one session.
They ingested a capsule that they brought to the testing site themselves, which they had obtained from an unknown source. Participants were given a choice of three doses to choose from, 10, 15 or 20 mg 2C-B, based on their stated preference from experience. They chose to take a mean 2C-B dose of 2cb urine test to participation all subjects were trained with respect to the procedures, tests, and questionnaires employed in the study.
Participants were requested to abstain from any drug use 48 hours h prior to the study session. Alcohol and caffeine-containing beverages were not allowed the 24 h or the morning of the study session. Sessions took place on different days at the home of a member of the PHI Association. The setting included ambience music except in the evaluation times.
Acute effects of the novel psychoactive drug 2c-b on emotions
Subjects could read, talk, play table games during sessions and interact. They were instructed not to talk about the effects of the substance during the session.
Assessments were performed at baseline predose, immediately before 2C-B self-administration and over 6 h after 2C-B self-administration. The experiments were conducted at the same time for all subjects, from to h. A light snack was ingested immediately after. Urine spot samples were collected before 2C-B administration to exclude drug use prior to the session MDMA, amphetamines, barbiturates, benzodiazepines, cocaine, marijuana, morphine, methamphetamine, phencyclidine with Instant-View, Multipanel 10 Test Drug Screen Alfa Scientific Des, Inc.
The sequence of procedures at each time point of the session was: vital s, physiological effects, oral fluid collection, subjective effect scales and questionnaires. Subjective effects were recorded at 2cb urine test and 2 h after administration, at 6 h subjects were asked to report the maximum effects along 6 h 0—6 h. Maximum effects E max and the time needed to reach maximum effects t max were also calculated for the mentioned variables.
The area under the curve of the concentrations AUC using the trapezoidal rule were calculated for vital s. Firstly, a two-way analysis of variance ANOVA test was conducted to study the influence of dose and gender in the different parameters calculated. Because the showed only marginal statistically ificant for interactions between dose and gender, dose or gender, the analysis was rejected nine variables showed ificant for a total of comparisons.
Subsequently, the statistical analysis presented was performed without considering these factors. E max values of vital s and cortisol were compared with baseline data using a paired samples t -test. Furthermore, a detailed comparison between different time points was performed by means of a one-way repeated measures ANOVA, with time condition as factor. When the time condition was statistically ificant, a Dunnett post hoc test was performed to compare the different time points with baseline.
For subjective effects, a one-way repeated measures ANOVA was performed with time condition as factor baseline, 2 and 6 h. When ANOVA has been statistically ificant a Dunnett post hoc test was performed to compare 2 and 6 h with baseline.
No comparison between 2 and 6 h maximum effects from 0 to 6 h was performed 2cb urine test both measures although obtained in different time points are an approximation of the same parameter E max. A total of 16 healthy subjects participated in the study eight males and eight females. They had a mean age of The mean 2C-B weight-adjusted dose was 0. They reported an average 2cb urine test use of 3 range: 1—20 times during their lifetime. All volunteers had recreational experience with MDMA, amphetamines, hallucinogens, cocaine, and cannabis.
Baseline drug urine tests were negative.
Time course of changes were similar to oral fluid concentration of 2C-B see below, Figure 1B. TABLE 1. Table 2 shows the for the different subscales of the questionnaires. TABLE 2. In comparison to baseline, statistical ificant changes were detected for all VAS scales with the exception of bad effects, hallucinations-seeing animals, things, insects, or people, hallucinations-hearings of sounds or voices, dizziness, fear, and depression or sadness.
In fact only five of the subjects described clear hallucinogenic effects in VAS. The most 2cb urine test increases compared to baseline were found for MBG euphoria and A amphetamine subscales. Modest increases were detected for LSD dysphoria and somatic symptoms and BG intellectual efficiency and energy subscales.
Analysis of 4-bromo-2,5-dimethoxyphenethylamine abuser's urine: identification and quantitation of urinary metabolites
For several subjective outcomes, mean peak effects reported at 6 h summary effects of the 0—6 h were slightly lower than scores obtained at 2 h after administration see Table 2. Nevertheless, when statistical differences from baseline were observed at 2 h, the same occurred for 6 h maximum effects from 0 to 6 h.
These differences between 2 and 6 h could be explained due to memory bias. With respect to the HRS, the highest scores were obtained for intensity, volition and affect subscales see Figure 2. Scores represent the maximum effects along 6 h after self-administration of 2C-B. Concentrations 2cb urine test rapidly from 2 to 6 h after ingestion and could be detected in oral fluid up to 24 h in half of the volunteers.
C max reached was 4.